GGrantIndex
← Leaderboards

Todd Justen Kilbaugh

University Of Kentucky

$6,809,834
Attributed
$8,784,988
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY201725
$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$8,784,988 · 4

By mechanism

R01$7,611,988 · 2
R41$700,000 · 1
R21$473,000 · 1

Top collaborators

Most similar at University Of Kentucky

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Production

Research focus

ProductionMediatingBrainDoseBrain InjuriesPublishingResponseBioenergeticsProdrugsNovel StrategiesMitochondrial DysfunctionInnovationMitochondriaClinically RelevantInjuryFamily SuidaeReactive Oxygen SpeciesComplexIn VivoNeuropathologyCognitive DeficitsCellsTissuesTranslations

Grant awards (15)

Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$683,169
R01 · FY2025 · NS
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$691,959
R01 · FY2024 · NS
Improving Pediatric Cardiac Arrest Survival and Neurologic Outcome$859,957
R01 · FY2023 · HL · contact PI
Improving Pediatric Cardiac Arrest Survival and Neurologic Outcome$866,180
R01 · FY2022 · HL · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$612,006
R01 · FY2022 · NS
Improving Pediatric Cardiac Arrest Survival and Neurologic Outcome$861,166
R01 · FY2021 · HL · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$620,851
R01 · FY2021 · NS
Improving Pediatric Cardiac Arrest Survival and Neurologic Outcome$877,372
R01 · FY2020 · HL · contact PI
Mitochondrial Uncoupling Prodrug as a Translational Therapy for TBI$642,323
R01 · FY2020 · NS
Novel monoclonal antibody for single dose treatment of acute CNS injury$200,000
R41 · FY2020 · NS
Novel monoclonal antibody for single dose treatment of acute CNS injury$43,953
R41 · FY2020 · NS
Improving Pediatric Cardiac Arrest Survival and Neurologic Outcome$897,005
R01 · FY2019 · HL · contact PI
Novel monoclonal antibody for single dose treatment of acute CNS injury$456,047
R41 · FY2019 · NS
Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats$258,000
R21 · FY2018 · NS · contact PI
Mitochondrial Targeted Biofuels as Countermeasures Against Chemical Threats$215,000
R21 · FY2017 · NS · contact PI